158 related articles for article (PubMed ID: 38385080)
1. GALNT12 suppresses the bone-specific prostate cancer metastasis by activating BMP pathway via the O-glycosylation of BMPR1A.
Yang Y; Ding M; Yin H; Chen W; Shen H; Diao W; Yang L; Qin H; Gan W; Qiu X; Guo H
Int J Biol Sci; 2024; 20(4):1297-1313. PubMed ID: 38385080
[TBL] [Abstract][Full Text] [Related]
2. Expression of GALNT8 and O-glycosylation of BMP receptor 1A suppress breast cancer cell proliferation by upregulating ERα levels.
Huang T; Wu Q; Huang H; Zhang C; Wang L; Wang L; Liu Y; Li W; Zhang J; Liu Y
Biochim Biophys Acta Gen Subj; 2022 Jan; 1866(1):130046. PubMed ID: 34743989
[TBL] [Abstract][Full Text] [Related]
3. GALNT12 is associated with the malignancy of glioma and promotes glioblastoma multiforme in vitro by activating Akt signaling.
Zheng Y; Liang M; Wang B; Kang L; Yuan Y; Mao Y; Wang S
Biochem Biophys Res Commun; 2022 Jun; 610():99-106. PubMed ID: 35461073
[TBL] [Abstract][Full Text] [Related]
4. Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers.
Guda K; Moinova H; He J; Jamison O; Ravi L; Natale L; Lutterbaugh J; Lawrence E; Lewis S; Willson JK; Lowe JB; Wiesner GL; Parmigiani G; Barnholtz-Sloan J; Dawson DW; Velculescu VE; Kinzler KW; Papadopoulos N; Vogelstein B; Willis J; Gerken TA; Markowitz SD
Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12921-5. PubMed ID: 19617566
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression.
Liu Y; Zhang RX; Yuan W; Chen HQ; Tian DD; Li H; Jiang X; Deng ZL; Wang Y
Cell Physiol Biochem; 2018; 45(5):1759-1771. PubMed ID: 29495003
[TBL] [Abstract][Full Text] [Related]
6. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment.
Morrissey C; Brown LG; Pitts TE; Vessella RL; Corey E
Neoplasia; 2010 Feb; 12(2):192-205. PubMed ID: 20126477
[TBL] [Abstract][Full Text] [Related]
8. Targeting the BMP Pathway in Prostate Cancer Induced Bone Disease.
Straign DM; Ihle CL; Provera MD; Owens P
Front Endocrinol (Lausanne); 2021; 12():769316. PubMed ID: 34956082
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
[TBL] [Abstract][Full Text] [Related]
10. Essential roles of epithelial bone morphogenetic protein signaling during prostatic development.
Omori A; Miyagawa S; Ogino Y; Harada M; Ishii K; Sugimura Y; Ogino H; Nakagata N; Yamada G
Endocrinology; 2014 Jul; 155(7):2534-44. PubMed ID: 24731097
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4.
Ye L; Kynaston H; Jiang WG
Mol Cancer Res; 2008 Oct; 6(10):1594-606. PubMed ID: 18922975
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.
Wa Q; Li L; Lin H; Peng X; Ren D; Huang Y; He P; Huang S
Oncol Rep; 2018 Jan; 39(1):81-90. PubMed ID: 29138858
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals.
Nishimori H; Ehata S; Suzuki HI; Katsuno Y; Miyazono K
J Biol Chem; 2012 Jun; 287(24):20037-46. PubMed ID: 22532569
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor up-regulates the expression of the bone morphogenetic protein (BMP) receptors, BMPR-IB and BMPR-II, in human prostate cancer cells.
Ye L; Lewis-Russell JM; Davies G; Sanders AJ; Kynaston H; Jiang WG
Int J Oncol; 2007 Feb; 30(2):521-9. PubMed ID: 17203235
[TBL] [Abstract][Full Text] [Related]
16. GRP78 promotes bone metastasis of prostate cancer by regulating bone microenvironment through Sonic hedgehog signaling.
Yang M; Weng K; Guo Y; Huang L; Chen J; Lu H
Mol Carcinog; 2024 Mar; 63(3):494-509. PubMed ID: 38085107
[TBL] [Abstract][Full Text] [Related]
17. Differential molecular regulation of processing and membrane expression of Type-I BMP receptors: implications for signaling.
Hirschhorn T; Levi-Hofman M; Danziger O; Smorodinsky NI; Ehrlich M
Cell Mol Life Sci; 2017 Jul; 74(14):2645-2662. PubMed ID: 28357470
[TBL] [Abstract][Full Text] [Related]
18. Role of bone morphogenetic proteins in human prostate cancer pathogenesis and development of bone metastases: immunohistochemical study.
Spanjol J; Djordjević G; Markić D; Klarić M; Fuckar D; Bobinac D
Coll Antropol; 2010 Apr; 34 Suppl 2():119-25. PubMed ID: 21302710
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion.
Wang W; Yang X; Dai J; Lu Y; Zhang J; Keller ET
Oncogene; 2019 Jun; 38(23):4540-4559. PubMed ID: 30755731
[TBL] [Abstract][Full Text] [Related]
20. Deletion of the BMP receptor BMPR1a impairs mammary tumor formation and metastasis.
Pickup MW; Hover LD; Guo Y; Gorska AE; Chytil A; Novitskiy SV; Moses HL; Owens P
Oncotarget; 2015 Sep; 6(26):22890-904. PubMed ID: 26274893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
